Predicting the need for hypoglycemic treatment for elevated blood glucose levels, a side effect of corticosteroid treatments such as collagen disease

Predicting the need for hypoglycemic treatment for elevated blood glucose levels, a side effect of corticosteroid treatments such as collagen disease - Predicting the need for hypoglycemic treatment for elevated blood glucose levels, a side effect of corticosteroid treatments such as collagen disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043480

Enrollment

500

Registered

2021-03-01

Start date

2020-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Collagen disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 20 years or older who were admitted to the Department of General Internal Medicine, Gifu University Hospital from June 1, 2004 to July 31, 2020, were diagnosed with collagen disease, and were given prednisolone 5 mg/day or more for 4 weeks or more

Exclusion criteria

Exclusion criteria: (1)patients who are already on hypoglycemic drugs at the start of prednisolone (2)patients who are taking 15 mg/day or more of prednisolone before admission (3)patients with anti-cancer chemotherapy (4)patients who offered to be excluded from the study

Design outcomes

Primary

Measure	Time frame
Blood glucose level	—

Countries

Japan

Contacts

Public ContactAyaka Kato

Gifu University Hospital Comprehensive pathology internal medicine

rinri@gifu-u.ac.jp058-230-6632

Outcome results